Type 1 diabetes mellitus (T1DM) is the third most common chronic childhood disease in the
United States. As more Hispanic and non-Hispanic black children are diagnosed with T1DM …

BACKGROUND AND OBJECTIVES: Previous research has documented racial/ethnic
disparities in diabetes treatments and outcomes. It remains controversial whether these …

Objective The aim of this study was to assess racial disparities in treatments and outcomes
between Non‐Hispanic black (NHB), Hispanic and Non‐Hispanic white (NHW) children with …

Diabetes, a leading cause of nephrop-athy, retinopathy, neuropathy, and coronary and
peripheral vascular disease, is the third most prevalent severe chronic disease of childhood …

OBJECTIVE To estimate the prevalence of diabetes in US youth aged< 20 years in 2009
and to estimate the total number of youth with diabetes in the US by age, race/ethnicity, and …

In 1997 an international expert committee working under the sponsorship of the American
Diabetes Association published revised criteria for the diagnosis and classification of …

Objective This study evaluated racial differences in the metabolic control of children and
adolescents with insulin-dependent (type I) diabetes mellitus and examined the interactive …

Objective. To determine whether the risk of death from type 1 insulin-dependent diabetes
mellitus (IDDM) was similar among young non-Hispanic black, non-Hispanic white, and …

Racial disparities in type 1 diabetes (T1D) treatment and outcomes have been extensively
described. In the United States, non-Hispanic Black children have higher rates of …

OBJECTIVE—To report the 2001 prevalence and 2002–2005 incidence of type 1 and type 2
diabetes in Hispanic American youth and to describe the demographic, clinical, and …